ENDP Endo International plc

Price (delayed)

$5.27

Market cap

$1.23B

P/E Ratio

17.57

Dividend/share

N/A

EPS

$0.3

Enterprise value

$7.85B

Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system. While Endo's management, operations, ...

Highlights
The EPS has soared by 144% YoY
ENDP's net income has surged by 144% year-on-year
Endo International's equity has decreased by 12% from the previous quarter but it has increased by 12% YoY
ENDP's price to earnings (P/E) is 32% higher than its last 4 quarters average of 13.3
The company's quick ratio fell by 20% YoY and by 4.6% QoQ

Key stats

What are the main financial stats of ENDP
Market
Shares outstanding
233.67M
Market cap
$1.23B
Enterprise value
$7.85B
Valuations
Price to earnings (P/E)
17.57
Price to book (P/B)
N/A
Price to sales (P/S)
0.42
EV/EBIT
16.15
EV/EBITDA
8.15
EV/Sales
2.65
Earnings
Revenue
$2.96B
EBIT
$486.17M
EBITDA
$963.97M
Free cash flow
$490.09M
Per share
EPS
$0.3
Free cash flow per share
$2.1
Book value per share
-$2.96
Revenue per share
$12.69
TBVPS
$13.84
Balance sheet
Total assets
$9.25B
Total liabilities
$9.94B
Debt
$8.32B
Equity
-$690.32M
Working capital
$1.19B
Liquidity
Debt to equity
-12.05
Current ratio
1.77
Quick ratio
1.44
Net debt/EBITDA
6.87
Margins
EBITDA margin
32.5%
Gross margin
56.8%
Net margin
2.3%
Operating margin
18.9%
Efficiency
Return on assets
0.7%
Return on equity
N/A
Return on invested capital
5.8%
Return on capital employed
6.3%
Return on sales
16.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ENDP stock price

How has the Endo International stock price performed over time
Intraday
-5.89%
1 week
-12.89%
1 month
13.82%
1 year
2.93%
YTD
-26.6%
QTD
62.65%

Financial performance

How have Endo International's revenue and profit performed over time
Revenue
$2.96B
Gross profit
$1.68B
Operating income
$560.59M
Net income
$68.16M
Gross margin
56.8%
Net margin
2.3%
ENDP's net income has surged by 144% year-on-year
Endo International's net margin has soared by 143% YoY but it has decreased by 8% from the previous quarter
Endo International's operating income has surged by 94% YoY and by 4.5% QoQ
The operating margin has soared by 91% year-on-year

Growth

What is Endo International's growth rate over time

Valuation

What is Endo International stock price valuation
P/E
17.57
P/B
N/A
P/S
0.42
EV/EBIT
16.15
EV/EBITDA
8.15
EV/Sales
2.65
The EPS has soared by 144% YoY
ENDP's price to earnings (P/E) is 32% higher than its last 4 quarters average of 13.3
Endo International's equity has decreased by 12% from the previous quarter but it has increased by 12% YoY
ENDP's price to sales (P/S) is 16% lower than its 5-year quarterly average of 0.5 and 16% lower than its last 4 quarters average of 0.5
Endo International's revenue has increased by 4.9% from the previous quarter

Efficiency

How efficient is Endo International business performance
Endo International's ROA has soared by 141% YoY but it has decreased by 13% from the previous quarter
Endo International's return on invested capital has surged by 107% YoY
The ROS has soared by 100% YoY but it has contracted by 4.1% from the previous quarter

Dividends

What is ENDP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ENDP.

Financial health

How did Endo International financials performed over time
The company's total assets is 7% lower than its total liabilities
The company's quick ratio fell by 20% YoY and by 4.6% QoQ
The current ratio has contracted by 18% YoY and by 2.7% from the previous quarter
The debt to equity has contracted by 13% YoY but it has grown by 11% from the previous quarter
Endo International's equity has decreased by 12% from the previous quarter but it has increased by 12% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.